Beauty Health (NASDAQ:SKIN) Lowered to “Strong Sell” Rating by Zacks Research

Zacks Research lowered shares of Beauty Health (NASDAQ:SKIN) from a hold rating to a strong sell rating in a research note published on Wednesday,Zacks.com reports.

SKIN has been the subject of a number of other research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Beauty Health in a report on Friday, October 31st. TD Cowen boosted their price target on Beauty Health from $1.50 to $1.65 and gave the company a “hold” rating in a report on Wednesday. Wall Street Zen downgraded Beauty Health from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, Jefferies Financial Group reissued a “hold” rating and issued a $1.60 target price on shares of Beauty Health in a research report on Wednesday, January 14th. One investment analyst has rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and a consensus price target of $2.40.

Beauty Health Price Performance

NASDAQ SKIN opened at $1.56 on Wednesday. The company has a debt-to-equity ratio of 5.53, a quick ratio of 4.07 and a current ratio of 4.98. The stock has a market cap of $198.90 million, a price-to-earnings ratio of -7.09 and a beta of 1.16. The business has a 50 day simple moving average of $1.45 and a 200 day simple moving average of $1.70. Beauty Health has a 52-week low of $0.78 and a 52-week high of $2.69.

Beauty Health (NASDAQ:SKIN) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($0.01). Beauty Health had a negative net margin of 3.87% and a negative return on equity of 19.70%. The company had revenue of $70.66 million during the quarter, compared to analyst estimates of $68.33 million. Analysts anticipate that Beauty Health will post -0.25 earnings per share for the current fiscal year.

Institutional Trading of Beauty Health

Institutional investors and hedge funds have recently bought and sold shares of the stock. Prescott Group Capital Management L.L.C. increased its holdings in Beauty Health by 29.2% during the second quarter. Prescott Group Capital Management L.L.C. now owns 835,939 shares of the company’s stock worth $1,597,000 after buying an additional 189,141 shares during the last quarter. Grimes & Company Inc. lifted its stake in Beauty Health by 85.2% in the second quarter. Grimes & Company Inc. now owns 406,987 shares of the company’s stock valued at $777,000 after acquiring an additional 187,226 shares during the last quarter. Mirabella Financial Services LLP grew its position in shares of Beauty Health by 5.0% in the 2nd quarter. Mirabella Financial Services LLP now owns 12,861,549 shares of the company’s stock valued at $24,566,000 after acquiring an additional 614,602 shares during the period. Newman Dignan & Sheerar Inc. increased its stake in shares of Beauty Health by 28.1% during the 2nd quarter. Newman Dignan & Sheerar Inc. now owns 91,144 shares of the company’s stock worth $174,000 after purchasing an additional 20,000 shares during the last quarter. Finally, Simplicity Wealth LLC bought a new stake in shares of Beauty Health in the 2nd quarter valued at about $49,000. Institutional investors own 93.26% of the company’s stock.

About Beauty Health

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.